Hypervision Surgical has raised £6.5 million for its surgical imaging and data analytics platform.

Based in London, the King’s College London spin-out harnesses AI and clinical edge computing. It aims to revolutionise surgical outcomes and alleviate the global burden of surgical complications across diverse surgical specialties.

“We are incredibly excited about the transformative potential of our Hyperspectral Intelligence platform,” said Michael Ebner, CEO and co-founder. 

“Imagine a complex tumour surgery where surgeons can rely on precise measurements and tissue property information to distinguish between healthy and unhealthy tissue.

“Our technology makes the invisible visible, empowering surgeons to make confident decisions with enhanced precision and ultimately improving patient outcomes.”

The funding round was led by a syndicate of highly experienced European and American HealthTech investors, including HERAN Partners, Redalpine, LifeX Ventures, and ZEISS Ventures, the corporate venture arm of the ZEISS Group – a global technology leader operating in the fields of optics and optoelectronics.

Hypervision Surgical

The funding will be used to attain regulatory clearance in the United States and Europe, the firm says. It will also look to expand collaborations with leading surgeons, renowned surgical centres and strategic industry partners on both sides of the Atlantic to ensure a successful market launch and smooth integration into clinical practice.

Additionally, the completion of UK clinical evaluation studies on colorectal and neurosurgery in the coming year will further enhance its evidence base, according to Hypervision Surgical.

TruSpine board survives shareholder revolt

Raf Roelands, investment director at HERAN Partners, stated: “Hypervision Surgical’s hardware-agnostic solution has the potential to redefine the standard of care in surgical imaging across various procedures, from open to minimally invasive, robotics and microscopic surgeries.”

It also welcomes Martin Frost CBE, founder and former CEO of CMR Surgical, to its board of directors. Frost has an extensive track record as a technology executive and director, having spent decades building and leading multiple companies, including through initial public offerings. 

He founded CMR Surgical in 2014 and swiftly scaled it into a globally recognised unicorn in the field of surgical robotics.

In recognition of his exceptional contributions to Robotics and the British Industry, Frost was awarded a CBE in the 2020 Queen’s Birthday Honours.

“We are thrilled to have Martin Frost join our board of directors,” said Ebner. “His unparalleled expertise in building and scaling surgical technology ventures will be invaluable as we navigate the next phase of Hypervision Surgical’s growth and commercialisation efforts.”

University spin-out secures £500k  from angels